These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35605838)

  • 1. Synthesis of a new series of quinoline/pyridine indole-3-sulfonamide hybrids as selective carbonic anhydrase IX inhibitors.
    Singh P; Sridhar Goud N; Swain B; Kumar Sahoo S; Choli A; Angeli A; Singh Kushwah B; Madhavi Yaddanapudi V; Supuran CT; Arifuddin M
    Bioorg Med Chem Lett; 2022 Aug; 70():128809. PubMed ID: 35605838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide based thiosemicarbazides as potent and selective inhibitors of tumor-associated human carbonic anhydrase IX and XII: Synthesis, cytotoxicity, and molecular modelling studies.
    Demir-Yazıcı K; Trawally M; Bua S; Öztürk-Civelek D; Akdemir A; Supuran CT; Güzel-Akdemir Ö
    Bioorg Chem; 2024 Mar; 144():107096. PubMed ID: 38290186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Pyridinium Salt Derivatives of 2-(Hydrazinocarbonyl)-3-phenyl-1H-indole-5- sulfonamide as Selective Inhibitors of Tumour-Related Human Carbonic Anhydrase Isoforms IX and XII.
    Güzel-Akdemir Ö; Demir-Yazıcı K; Vullo D; Supuran CT; Akdemir A
    Anticancer Agents Med Chem; 2022; 22(14):2637-2646. PubMed ID: 35135455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Novel Indole-3-sulfonamide-heteroaryl Hybrids as Carbonic Anhydrase Inhibitors: Design, Synthesis and
    Chinchilli KK; Singh P; Swain B; Goud NS; Sigalapalli DK; Choli A; Angeli A; Nanduri S; Yaddanapudi VM; Supuran CT; Arifuddin M
    Anticancer Agents Med Chem; 2023; 23(11):1225-1233. PubMed ID: 36847230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and development of novel series of indole-3-sulfonamide ureido derivatives as selective carbonic anhydrase II inhibitors.
    Singh P; Choli A; Swain B; Angeli A; Sahoo SK; Yaddanapudi VM; Supuran CT; Arifuddin M
    Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100333. PubMed ID: 34694638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of 2-phenylquinoline-4-carboxamide linked benzene sulfonamide derivatives as isoform selective inhibitors of transmembrane human carbonic anhydrases.
    Swain B; Sahoo SK; Singh P; Angeli A; Yaddanapudi VM; Supuran CT; Arifuddin M
    Eur J Med Chem; 2022 Apr; 234():114247. PubMed ID: 35305463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ureidosulfocoumarin Derivatives As Selective and Potent Carbonic Anhydrase IX and XII Inhibitors.
    Singh P; Kumar Sigalapalli D; Sridhar Goud N; Swain B; Kumar Sahoo S; Angeli A; Shaik AB; Madhavi Yaddanapudi V; Supuran CT; Arifuddin M
    ChemMedChem; 2022 Mar; 17(5):e202100725. PubMed ID: 34898017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coumarin-pyrazoline Hybrids as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII.
    Redij A; Carradori S; Petreni A; Supuran CT; Toraskar MP
    Anticancer Agents Med Chem; 2023; 23(10):1217-1223. PubMed ID: 36825712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors.
    Chandra KM; Goud NS; Arifuddin M; Alvala M; Alvala R; Angeli A; Supuran CT
    Bioorg Med Chem Lett; 2021 May; 39():127877. PubMed ID: 33640442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids.
    Singh P; Swain B; Thacker PS; Sigalapalli DK; Purnachander Yadav P; Angeli A; Supuran CT; Arifuddin M
    Bioorg Chem; 2020 Jun; 99():103839. PubMed ID: 32289586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors.
    Cornelio B; Laronze-Cochard M; Miambo R; De Grandis M; Riccioni R; Borisova B; Dontchev D; Machado C; Ceruso M; Fontana A; Supuran CT; Sapi J
    Eur J Med Chem; 2019 Aug; 175():40-48. PubMed ID: 31071549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of coumarin-1,3,4-oxadiazole hybrids as selective carbonic anhydrase IX and XII inhibitors.
    Narella SG; Shaik MG; Mohammed A; Alvala M; Angeli A; Supuran CT
    Bioorg Chem; 2019 Jun; 87():765-772. PubMed ID: 30974299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coumarin and Piperazine Conjugates as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII Isoforms.
    Sethi A; Munagalasetty S; Arifuddin M; Carradori S; Supuran CT; Alvala R; Alvala M
    Anticancer Agents Med Chem; 2023; 23(10):1184-1191. PubMed ID: 36733240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
    Ghorab MM; Soliman AM; Bua S; Supuran CT
    Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII.
    Chandak N; Ceruso M; Supuran CT; Sharma PK
    Bioorg Med Chem; 2016 Jul; 24(13):2882-2886. PubMed ID: 27137360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.